Product Information
SINUS-HEADACHE 5-325 MG CAPLET is a generic product labeled by Cardinal Health, priced at $0.0853 per EA under NDC 70000056801. Its NADAC has been published 291 times since Mar 10, 2021.
Strength
325; 5 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000056801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/26/2005
Pharmacological Classes
Price Statistics
The NADAC for SINUS-HEADACHE 5-325 MG CAPLET has been published 291 times since Mar 10, 2021, and over the history we have for it it has risen 68.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0853 per EA |
|---|---|
| All-time high | $0.0905 (Mar 15, 2023) |
| All-time low | $0.0488 (Dec 22, 2021) |
| 52-week high | $0.0854 |
| 52-week low | $0.0800 |
| Median price | $0.0752 |
| Average price | $0.0731 |
| Largest weekly change | +45.2% (Feb 22, 2023) |
| Weeks tracked | 291 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen and Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen and Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SINUS-HEADACHE 5-325 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for SINUS-HEADACHE 5-325 MG CAPLET, manufactured by Cardinal Health, is $0.0853 per EA (NDC 70000056801), effective Sep 30, 2026.
How has the price of SINUS-HEADACHE 5-325 MG CAPLET changed over time?
Over the history we have for it, the NADAC for SINUS-HEADACHE 5-325 MG CAPLET has risen 68.6%. It has been tracked across 291 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for SINUS-HEADACHE 5-325 MG CAPLET?
Since Mar 10, 2021, the NADAC for SINUS-HEADACHE 5-325 MG CAPLET has ranged from a low of $0.0488 (Dec 22, 2021) to a high of $0.0905 (Mar 15, 2023), with a median of $0.0752 per EA.
Are there cheaper alternatives to SINUS-HEADACHE 5-325 MG CAPLET?
No other NADAC-published product currently shares the active ingredient and strength of SINUS-HEADACHE 5-325 MG CAPLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SINUS-HEADACHE 5-325 MG CAPLET?
SINUS-HEADACHE 5-325 MG CAPLET (NDC 70000056801) is labeled by Cardinal Health, and CMS classifies it as a generic product.